Flexible sigmoidoscopy (FS) screening has been shown to reduce colorectal cancer (CRC) incidence and mortality among screened adults. The aim of this review was to identify patient-related factors associated with the screening test's use.
Flexible sigmoidoscopy (FS) screening has been shown to reduce colorectal cancer (CRC) incidence and mortality among screened adults. The aim of this review was to identify patient-related factors associated with the screening test's use.
We searched PubMed for studies that examined the association between FS screening use and one or more factors. To determine the eligibility of studies, we first reviewed titles, then abstracts, and finally the full paper. We started with a narrow search, which we expanded successively (by adding 'OR' terms) until the number of new publications eligible after abstract review was < 1% of the total number of publications. We then abstracted factors from eligible papers and reported the number of times each was found to be positively or negatively associated with FS screening use.
We identified 42 papers, most of which reported studies conducted in the United States of America (n = 21, 50%) and the United Kingdom (n = 13, 31%). Across studies, a wide range of factors were examined (n = 123), almost half of which were found to be associated with FS screening use at least once (n = 60). Sociodemographic and health and lifestyle factors that were frequently positively associated with FS screening use included: male gender, higher socioeconomic status and a family history of CRC. Frequently positively associated psychosocial factors included low perceived barriers and high perceived benefits.
Findings suggest that future research should focus on developing a theoretical framework of cancer screening behaviour to allow a greater level of consistency and specificity in measuring key constructs.
Background
Colorectal cancer (CRC) is a leading cause of morbidity and mortality in Europe and North America (Ferlay et al., 2015) . Several large randomised controlled trials (RCTs) have shown that a single flexible sigmoidoscopy (FS) screen between the ages of 55 and 64 can significantly reduce the incidence and mortality of the disease among people who complete the test (Elmunzer et al., 2012) . As a result, several countries have begun implementing FS-based screening programmes for the early detection and prevention of CRC (Bevan and Rutter, 2018) , with England currently rolling out the test as part of its national Bowel Cancer Screening Programme (BCSP), and some healthcare and insurance providers offering it as one of several screening test options in the United States of America (USA). Power et al., 2008; Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011) , and having a preference for the gender of the practitioner performing the test . To date, reviews of these studies have combined findings with those focusing on factors associated with other CRC screening tests, such as colonoscopy and FIT (Beydoun and Beydoun, 2008; Wools et al., 2015) . For example, in a recent review by Wools and colleagues, findings from studies examining factors associated with colonoscopy screening use and FS screening use were combined to report factors associated with 'lower endoscopy' screening use (Wools et al., 2015) . While such reviews are useful in terms of identifying factors broadly associated with groups of CRC screening tests, they fail to explore important intrinsic differences between tests which might affect peoples' willingness to do each test differently. For example, FS only looks at the rectum and sigmoid colon (Atkin et al., 1993) , while colonoscopy examines the whole of the large bowel, resulting in the need for a more intensive bowel preparation, a longer time for the procedure, and a higher complication rate (Whitlock et al., 2008) .
The aim of this review, therefore, was to identify factors that have been frequently associated with FS screening use specifically. The results will be used to inform the development of interventions to promote uptake within the English Bowel Cancer Screening Programme as part of a research project funded by Yorkshire Cancer Research.
Methods

Search strategy and study selection
We searched PubMed (March 2018) for studies that examined the association between one or more patient-related factors and FS screening use. To be eligible, a full text English article had to be available. Studies were excluded if they examined the association between patient-related factors and non-screening FS, or any other lower endoscopic screening test. Trials which examined the impact of one or more interventions on FS screening use were also excluded, as were qualitative studies. No other limitations were set in terms of the year of publication or study design.
An answer to our research question was required within a relatively short timeframe (six months were allocated to the development of interventions for our Yorkshire Cancer Research study), and so a rapid review of the available literature was performed. As such, rather than using the customary search strategy associated with systematic reviews, which begin as comprehensively as possible, we began with a narrow search and expanded successively (by adding 'OR' terms) until the number of new publications eligible on abstract review was < 1% of the total (see Table 1 ). The major assumption with this method was that, if successive expansions yield diminishing numbers of potentially eligible publications, and the most recent expansion yields a relatively small addition to the pool, stopping the expansion at this point is unlikely to lead to a major loss of information. This search strategy has previously been described by Duffy and colleagues, who found that 92% of papers were identified prior to reference list searches (i.e. 60 of 65 papers were identified through the search strategy alone) (Duffy et al., 2017) .
The combination and order in which search terms were entered was based on the total number of new publications obtained at each stage (i.e. the combination with the highest yield was selected for each stage; this was to ensure we did not arrive at a final search yielding < 1% of new publications potentially eligible for inclusion prematurely). All papers were assessed by two reviewers (RK and VW). Each reviewer assigned papers a value of 1 ('include') or 0 ('exclude'). Discrepancies between reviewer scores were resolved through discussion. Papers passing title and abstract review underwent full paper review. The reference lists of papers eligible after full paper review were searched for further potential papers that, in turn, were subject to abstract and, if eligible, full paper review. The same process was applied to the Table 1 Results of successively broadening the search terms until newly identified papers potentially eligible on abstract review was < 1% of the total papers found by the search. R.S. Kerrison et al. Preventive Medicine 120 (2019) 8-18 reference lists of reviews detected through the searches (DeBarros and Steele, 2013; Donovan and Syngal, 1998; St, 2000; Winawer et al., 1990; Janes et al., 1999; Menees and Fenner, 2007) , with two reviewers assessing the title, abstract and full paper of any potentially eligible new papers.
Data collection
Data on the first author, year of publication, study setting, programme delivery (i.e. organised vs. opportunistic), study design, context (i.e. real life vs. RCT/pilot programme), sample size, outcome, analysis, gender of participants, factors examined and results were abstracted from eligible papers. The list of factors accumulated was then categorised into 'sociodemographic', 'health and lifestyle' and 'psychosocial' factors. For the purposes of this study, sociodemographic variables were defined as 'statistical data about the characteristics of a population', while health and lifestyle factors were defined as 'factors that described the health behaviours, perceived health and previous medical history of individuals'. Psychosocial variables were defined as those variables that examined 'psychological attributes' (SinghManoux, 2003) . To decide whether factors were significantly associated with FS screening use, we used the cut-off p-value used to define statistical significance within each individual study.
Data analysis
Cohen's kappa was used to assess inter-rater agreement for the database and reference list searches (Cohen, 1960) . Descriptive statistics were used to report the characteristics of studies and the number of times factors were examined and found to be positively or negatively associated with FS screening use. The data were managed within SPSS Ver. 25.0.
Results
Study characteristics
After abstract review, 26 papers were deemed eligible. On full paper review, 4 were then excluded. From the reference lists of the remaining papers, and the six identified review papers, a further 20 were added, bringing the total number of papers included to 42. Inter-rater agreement for the database and reference list searches was 'very high' (Cohen's kappa for the database and reference list searches was 0.87 and 0.92, respectively).
The basic attributes of the included studies are presented in Table 2 (a more detailed overview is presented in Appendix 1). The majority of papers reported studies performed in the USA (n = 21, 50%) or the UK (n = 13, 31%), examined screening use within opportunistic programmes (n = 22, 52.4%), employed cross-sectional designs (n = 30, 71.4%), had sample sizes of > 1000 participants (n = 24, 57.1%), and assessed having attended/ever had a once-only FS screening appointment (n = 29, 65.9%).
Factors
Across the 42 studies, 123 factors were examined (25 sociodemographic factors, 50 health and lifestyle factors, and 48 psychosocial factors). The frequencies of factors found to be significantly positively or negatively associated with FS screening use at least once are reported in Table 3 . All consistently non-significant factors are reported in the appendix (see Appendix 2).
Sociodemographic factors
The most frequently examined sociodemographic factors were: gender (n = 28) Sutton et al., 2000; Whitaker et al., 2011; Walsh et al., 2004; Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Lawsin et al., 2007; Taylor et al., 2003; Yip et al., 2006; Blom et al., 2008; Hol et al., 2009; McGregor et al., 2016; Robb et al., 2010; Van Jaarsveld et al., 2006; Kang and Bloom, 1993; McCaffery et al., 2002; Bevan et al., 2015; Brotherstone et al., 2007; Juon et al., 2003; Segnan et al., 2007; Investigators, 2002; Bostick et al., 1993; van Dam et al., 2013; Kremers et al., 2000; Senore et al., 2010; , age (n = 26) Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Walsh et al., 2004; Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Lawsin et al., 2007; Taylor et al., 2003; Yip et al., 2006; Hol et al., 2009; Van Jaarsveld et al., 2006; Kang and Bloom, 1993; McCaffery et al., 2002; Juon et al., 2003; Segnan et al., 2007; Bostick et al., 1993; van Dam et al., 2013; Kremers et al., 2000; Senore et al., 2010; Richardson et al., 1995; Ruffin et al., 2000) , education (n = 15) Walsh et al., 2004; Lawsin et al., 2007; Taylor et al., 2003; Blom et al., 2008; Van Jaarsveld et al., 2006; Juon et al., 2003; van Dam et al., 2013; Kremers et al., 2000; Senore et al., 2010; Richardson et al., 1995; Bostick et al., 1994) , marital status (n = 12) Power et al., 2008; Wardle et al., 2005; Lawsin et al., 2007; Taylor et al., 2003; Blom et al., 2008; Van Jaarsveld et al., 2006; Juon et al., 2003; van Dam et al., 2013; Bostick et al., 1994) , socioeconomic status (n = 10) Wardle et al., 2005; Whitaker et al., 2011; Hol et al., 2009; McGregor et al., 2016; Robb et al., 2010; McCaffery et al., 2002; Bevan et al., 2015; Brotherstone et al., 2007; van Dam et al., 2013) , ethnicity (n = 9) Walsh et al., 2004; Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Robb et al., 2008) , income (n = 6) Walsh et al., 2004; Lawsin et al., 2007; Blom et al., 2008; Kang and Bloom, 1993; Bostick et al., 1994) and employment status (n = 5) Wardle et al., 2005; van Dam et al., 2013; Senore et al., 2010; . Those most frequently positively associated with FS screening use included: male gender (n = 12/28; 42.9%) Whitaker et al., 2011; Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Hol et al., 2009; McGregor et al., 2016; Van Jaarsveld et al., 2006; McCaffery et al., 2002; Segnan et al., 2007; Bostick et al., 1993; , higher socioeconomic status (n = 9/10; 90%) Wardle et al., 2005; Whitaker et al., 2011; Hol et al., 2009; McGregor et al., 2016; Robb et al., 2010; McCaffery et al., 2002; Bevan et al., 2015; Brotherstone et al., 2007) , older age (n = 5/ 26; 19.2%) Janz et al., 2003; Walsh et al., 2002; Hol et al., 2009; Ruffin et al., 2000) , higher education (n = 4/15; 26.6%) Van Jaarsveld et al., 2006; Kang and Bloom, 1993; Bostick et al., 1994) , being married (n = 4/12; 33.3%) Blom et al., 2008; Van Jaarsveld et al., 2006; Juon et al., 2003) and White, Black, or Hispanic ethnicity (n = 5/9; 55.6%) Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Robb et al., 2008) . Other sociodemographic factors examined less frequently, but found to be positively associated with FS screening use at least once, included: higher income (n = 2/6; 33.3%) Bostick et al., 1994) , having a full time job (n = 1; 20%) and being a home owner (n = 1; 100%) . Negative associations were reported for two factors: older age (n = 1/26; 3.9%) and male gender (n = 1/28; 3.6%) . No statistically significant positive or negative associations were reported for 11/25 (44%) sociodemographic factors (see Appendix 2), including social network index Bostick et al., 1994) and access to a car or van . Walsh et al., 2004; Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Lawsin et al., 2007; Taylor et al., 2003; Yip et al., 2006; Kang and Bloom, 1993; Juon et al., 2003; Bostick et al., 1993; Richardson et al., 1995; Ruffin et al., 2000; Bostick et al., 1994; Muldoon et al., 1996; Shapiro et al., 2001; Rawl et al., 2004; Thrasher et al., 2002 ) UK 13 (31.0%) Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; McGregor et al., 2016; Robb et al., 2010; Van Jaarsveld et al., 2006; McCaffery et al., 2002; Bevan et al., 2015; Brotherstone et al., 2007; Investigators, 2002; Robb et al., 2008; Vrinten et al., 2015) The Netherlands 3 (7.0%) van Dam et al., 2013; Kremers et al., 2000) Italy 2 (4.8%) Senore et al., 2010 ) Germany 1 (2.4%) (Gölder et al., 2007 ) Sweden 1 (2.4%) ) Norway 1 (2.4%) (Larsen et al., 2006) Programme delivery Opportunistic screening 22 (52.4%) Walsh et al., 2004; Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Lawsin et al., 2007; Taylor et al., 2003; Yip et al., 2006; Kang and Bloom, 1993; Juon et al., 2003; Bostick et al., 1993; Richardson et al., 1995; Ruffin et al., 2000; Bostick et al., 1994; Muldoon et al., 1996; Gölder et al., 2007; Shapiro et al., 2001; Rawl et al., 2004; Thrasher et al., 2002 ) Organised screening 20 (47.6%) Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Blom et al., 2008; Hol et al., 2009; McGregor et al., 2016; Robb et al., 2010; Van Jaarsveld et al., 2006; McCaffery et al., 2002; Bevan et al., 2015; Brotherstone et al., 2007; Segnan et al., 2007; Investigators, 2002; van Dam et al., 2013; Kremers et al., 2000; Senore et al., 2010; Robb et al., 2008; Larsen et al., 2006; Vrinten et al., 2015) Study design Cross-sectional 30 (71.4%) Walsh et al., 2004; Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Taylor et al., 2003; Yip et al., 2006; Hol et al., 2009; McGregor et al., 2016; Robb et al., 2010; Van Jaarsveld et al., 2006; Kang and Bloom, 1993; Bevan et al., 2015; Brotherstone et al., 2007; Juon et al., 2003; Segnan et al., 2007; Investigators, 2002; Bostick et al., 1993; van Dam et al., 2013; Senore et al., 2010; Richardson et al., 1995; Ruffin et al., 2000; Bostick et al., 1994; Muldoon et al., 1996; Shapiro et al., 2001; Rawl et al., 2004; Vrinten et al., 2015; Thrasher et al., 2002 ) Prospective 11 (26.2%) Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Lawsin et al., 2007; Blom et al., 2008; McCaffery et al., 2002; Kremers et al., 2000; Robb et al., 2008; Gölder et al., 2007) Prospective and retrospective 1 (2.4%) (Larsen et al., 2006) Context Real world context 22 (52.4%) Walsh et al., 2004; Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Lawsin et al., 2007; Taylor et al., 2003; Yip et al., 2006; McGregor et al., 2016; Kang and Bloom, 1993; Juon et al., 2003; Bostick et al., 1993; Richardson et al., 1995; Ruffin et al., 2000; Bostick et al., 1994; Muldoon et al., 1996; Shapiro et al., 2001; Rawl et al., 2004; Thrasher et al., 2002 ) Pilot programme 6 (14.3%) Robb et al., 2010; Bevan et al., 2015; Brotherstone et al., 2007; Kremers et al., 2000; Gölder et al., 2007 ) RCT 14 (33.3%) Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Hol et al., 2009; Van Jaarsveld et al., 2006; McCaffery et al., 2002; Segnan et al., 2007; Investigators, 2002; van Dam et al., 2013; Senore et al., 2010; Robb et al., 2008; Larsen et al., 2006; Vrinten et al., 2015) Sample size < 100 1 (2.4%) ) 100-299 9 (21.4%) Lawsin et al., 2007; Yip et al., 2006; Juon et al., 2003; Kremers et al., 2000; Rawl et al., 2004 ) 300-999 8 (19.1%) Walsh et al., 2004; Janz et al., 2003; Kang and Bloom, 1993; Brotherstone et al., 2007; van Dam et al., 2013; Senore et al., 2010; Gölder et al., 2007 Gölder et al., ) 1000 14 (33.3%) Sutton et al., 2000; Blom et al., 2008; Hol et al., 2009; Robb et al., 2010; Van Jaarsveld et al., 2006; Bevan et al., 2015; Bostick et al., 1993; Richardson et al., 1995; Bostick et al., 1994; Robb et al., 2008; Muldoon et al., 1996; Vrinten et al., 2015; Thrasher et al., 2002 ) 5000-50,000 7 (16.7%) Walsh et al., 2002; McGregor et al., 2016; McCaffery et al., 2002; Segnan et al., 2007; Ruffin et al., 2000; Larsen et al., 2006 ) > 50,000 3 (7.1%) Investigators, 2002; Shapiro et al., 2001) Outcome Attendance/non-attendance at onceonly FS 22 (52.4%) Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Blom et al., 2008; Hol et al., 2009; McGregor et al., 2016; Robb et al., 2010; Van Jaarsveld et al., 2006; McCaffery et al., 2002; Bevan et al., 2015; Brotherstone et al., 2007; Segnan et al., 2007; Investigators, 2002; van Dam et al., 2013; Kremers et al., 2000; Senore et al., 2010; Robb et al., 2008; Gölder et al., 2007; Larsen et al., 2006; Vrinten et al., 2015 ) Ever had FS 6 (14.2%) Kang and Bloom, 1993; Juon et al., 2003; Bostick et al., 1993; Bostick et al., 1994) Up to date with FS 13 (31.0%) Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Lawsin et al., 2007; Taylor et al., 2003; Yip et al., 2006; Richardson et al., 1995; Ruffin et al., 2000; Muldoon et al., 1996; Shapiro et al., 2001; Rawl et al., 2004 ) Ever had FS and up to date with FS 1 (2.4%) (Thrasher et al., 2002) (continued on next page) R.S. Kerrison et al. Preventive Medicine 120 (2019) 8-18 
Health and lifestyle factors
The most frequently examined health and lifestyle factors were: family history of CRC (n = 10) Sutton et al., 2000; Wardle et al., 2005; Janz et al., 2003; Walsh et al., 2002; Blom et al., 2008; Gölder et al., 2007) , perceived health (n = 9) Sutton et al., 2000; Wardle et al., 2005; Kang and Bloom, 1993; Juon et al., 2003; van Dam et al., 2013; Senore et al., 2010; Richardson et al., 1995; , insurance status (n = 7) Walsh et al., 2004; Walsh et al., 2002; Yip et al., 2006; Kang and Bloom, 1993; Juon et al., 2003; , smoking status (n = 6) van Dam et al., 2013; Senore et al., 2010; Bostick et al., 1994; Larsen et al., 2006; Shapiro et al., 2001) , recent bowel symptoms (n = 4) Sutton et al., 2000; Wardle et al., 2005; van Dam et al., 2013) , recent mammography (n = 4) Walsh et al., 2002; Shapiro et al., 2001) , physical activity (n = 4) Senore et al., 2010; Larsen et al., 2006; Shapiro et al., 2001 ) and chronic illness (n = 3) Bostick et al., 1994; Larsen et al., 2006) . Those most frequently positively associated with FS screening use included: a family history of CRC (n = 5/10; 50%) Walsh et al., 2002; Blom et al., 2008; Gölder et al., 2007) , good perceived health (n = 4/9; 44.4%) Sutton et al., 2000; Wardle et al., 2005; Richardson et al., 1995) , being a current nonsmoker or smoking fewer than 20 cigarettes a day (n = 3/6; 50%) Larsen et al., 2006; Shapiro et al., 2001) , one or more recent bowel symptoms (n = 2/4; 50%) Wardle et al., 2005) , having health insurance (n = 2/7; 28.6%) Janz et al., 2003) and attending a breast screen within the last three years (n = 2/4; 50%) Shapiro et al., 2001) . Other health and lifestyle factors examined less frequently, but found to be positively associated with FS screening use at least once, included: visiting a physician within the past year (n = 1/1; 100%) , having a pap smear (n = 1/2; 50%) (Shapiro et al., 2001) or cholesterol check within the past year (n = 1/1; 100%) (Shapiro et al., 2001) , having a usual source of care (n = 1/1; 100%) and visiting the physician regularly (n = 1/1; 100%) . Negative associations were reported for two factors: chronic conditions (n = 1/3; 33.3%) and frequent GP visits within the past three months (n = 1/2; 50%) . No statistically significant positive or negative associations were reported for 25 (50%) health and lifestyle factors (see Appendix 2), including alcohol consumption (Larsen et al., 2006) and being overweight (Larsen et al., 2006) .
Psychosocial factors
The most frequently examined psychosocial factors were perceived barriers (n = 7) Power et al., 2008; Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Rawl et al., 2004) , perceived benefits (n = 7) Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Janz et al., 2003; Senore et al., 2010) , perceived risk (n = 9) Power et al., 2008; Sutton et al., 2000; Wardle et al., 2005; Ko et al., 2005; van Dam et al., 2013; Kremers et al., 2000; Senore et al., 2010; , attitudes towards medical tests (n = 3) Sutton et al., 2000; Senore et al., 2010) , anticipated regret (n = 2) van Dam et al., 2013) and receipt of a physician recommendation to have the test (n = 2) Taylor et al., 2003) . Those most frequently positively associated with FS screening use included lower perceived barriers (n = 7/7, 100%) Power et al., 2008; Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Rawl et al., 2004) , higher perceived benefits (n = 5/7; 71.4%) Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; , higher perceived risk (n = 2/9; 22.2%) Kremers et al., 2000) , receipt of a recommendation from the clinician to have the test (n = 2/4; 50%) Taylor et al., 2003) and positive attitudes towards medical tests (n = 2/3; 66.7%) Sutton et al., 2000) . Other psychosocial factors found to be positively associated with FS screening use at least once, included: lower perceived test pain (n = 1/1; 100%) , higher consideration of future consequences (n = 1/1; 100%) , higher acculturation (n = 1/2; 50%) Table 3 Barriers and facilitators of FS screening use. -1 (10%) White or Black or Hispanic ethnicity 9 Walsh et al., 2004; Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Robb et al., 2008) 5 (55.6%) Ko et al., 2005; Janz et al., 2003; Walsh et al., 2002; Robb et al., 2008) -4 (44.4%) High income 6 Walsh et al., 2004; Lawsin et al., 2007; Blom et al., 2008; Kang and Bloom, 1993; Bostick et al., 1994) 2 (33.3%) Bostick et al., 1994) -4 (66.7%) Walsh et al., 2004; Lawsin et al., 2007; Kang and Bloom, 1993) Being in employment 5 Wardle et al., 2005; van Dam et al., 2013; Senore et al., 2010; 1 (20%) -4 (80%) van Dam et al., 2013; Senore et al., 2010; Inviting hospital or screening centre 2 McGregor et al., 2016) 2 (100%) McGregor et al., 2016) --City of residents home address 2 Robb et al., 2008) 1 (50%) -1 (50%) (continued on next page) R.S. Kerrison et al. Preventive Medicine 120 (2019) 8-18 (Muldoon et al., 1996) 1 (100%) (Muldoon et al., 1996) --Partner in home 1 1 (100%) --Being a home owner 1 1 (100%) --
Health and lifestyle factors (n = 25)
A family history of CRC 10 Sutton et al., 2000; Wardle et al., 2005; Janz et al., 2003; Walsh et al., 2002; Blom et al., 2008; Gölder et al., 2007) 5 (50%) Walsh et al., 2002; Blom et al., 2008; Gölder et al., 2007) -5 (50%) Sutton et al., 2000; Janz et al., 2003; A family history of cancer (excl.
CRC)
2 Gölder et al., 2007) 1 (50%) (Gölder et al., 2007) -1 (50%) A family history of sigmoidoscopy 1 1 (100%) --A personal history of GI disease 1 1 (100%) --Perceived health status good 9 Sutton et al., 2000; Wardle et al., 2005; Kang and Bloom, 1993; Juon et al., 2003; van Dam et al., 2013; Senore et al., 2010; Richardson et al., 1995; 4 (44.4%) Sutton et al., 2000; Wardle et al., 2005; Richardson et al., 1995) -7 (77.8%) Juon et al., 2003; van Dam et al., 2013; Senore et al., 2010; One or recent more bowel symptoms 4 Sutton et al., 2000; Wardle et al., 2005; van Dam et al., 2013) 2 (50%) Wardle et al., 2005) -2 (50%) van Dam et al., 2013) One of more chronic conditions 3 Bostick et al., 1994; Larsen et al., 2006) -1 (33.3%) ) 2 (66.7%) Larsen et al., 2006) Health insurance 7 Walsh et al., 2004; Walsh et al., 2002; Yip et al., 2006; Kang and Bloom, 1993; Juon et al., 2003; 2 (28.6%) Walsh et al., 2002) -5 (71.4%) Yip et al., 2006; Kang and Bloom, 1993; Juon et al., 2003; A regular source of care 2 Richardson et al., 1995) 1 (50%) -1 (50%) Clinician advice, received 1 1 (100%) Bostick et al., 1994) 1 (100%) --Frequent GP visits in past three months 2 Wardle et al., 2005) -1 (50%) (Wardle et al., 2005) 1 (50%) Visit physician regularly 1 1 (100%) --Breast screen in last three years 4 Walsh et al., 2002; Shapiro et al., 2001) 2 (50%) Shapiro et al., 2001) -2 (50%) Cervical screen in last three years 2 Shapiro et al., 2001) 1 (50%) (Shapiro et al., 2001) -1 (50%) Cholesterol check in past 2 years 1 (Shapiro et al., 2001) 1 (100%) (Shapiro et al., 2001 )
Smoking status, current nonsmoker 6 van Dam et al., 2013; Senore et al., 2010; Bostick et al., 1994; Larsen et al., 2006; Shapiro et al., 2001) 3 (50%) Larsen et al., 2006; Shapiro et al., 2001) -3 (50%) Senore et al., 2010; Bostick et al., 1994) Regular exercise 4 Senore et al., 2010; Larsen et al., 2006; Shapiro et al., 2001) 1 (25%) (Shapiro et al., 2001) -3 (75%) Senore et al., 2010; Larsen et al., 2006) Daily fruit and vegetable servings 1 (Shapiro et al., 2001) 1 (100%) (Shapiro et Lower perceived barriers 7 Power et al., 2008; Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Rawl et al., 2004) 7 (100%) Power et al., 2008; Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Rawl et al., 2004) --Higher perceived benefits 7 Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; Janz et al., 2003; Senore et al., 2010) 5 (71.4%) Sutton et al., 2000; Wardle et al., 2005; Whitaker et al., 2011; -2 (28.6%) Senore et al., 2010) Higher perceived risk 9 Power et al., 2008; Sutton et al., 2000; Wardle et al., 2005; Janz et al., 2003; van Dam et al., 2013; Kremers et al., 2000; Senore et al., 2010; 2 (22.2%) Kremers et al., 2000) -7 (77.8%) Power et al., 2008; Sutton et al., 2000; Wardle et al., 2005; van Dam et al., 2013; Higher general self-efficacy 1 1 (100%) (Kremers et -1 (100%) (Vrinten et al., 2015) Lower perceived test pain 1 1 (100%) --Higher consideration of future consequences 1 1 (100%) --Higher acculturation 2 Walsh et al., 2004) 1 (50%) -1 (50%) Knowledge of FS 1 1 (100%) --Physician recommendation 2 Taylor et al., 2003) 2 (100%) Taylor et al., 2003) --Family recommendation 1 1 (100%) --Previously thought about getting test 1 1 (100%) --MD gender preference 1 -1 (100%) -R.S. Kerrison et al. Preventive Medicine 120 (2019) 8-18 previously thought about getting the test done (n = 1/1; 100%) and positive attitudes towards CRC screening tests (n = 1/ 1; 100%) . Negative associations were reported for two factors: finding thoughts about cancer uncomfortable (n = 1/1; 100%) (Vrinten et al., 2015) and having a preferred MD gender (n = 1/ 1; 100%) . No statistically significant positive or negative associations were reported for 27/58 (46.6%) psychosocial factors (see Appendix 2), including perceived severity Kremers et al., 2000) and worry about bowel cancer Wardle et al., 2005) .
Variance
Three studies reported the amount of variance explained by their models Whitaker et al., 2011; Janz et al., 2003) . This ranged from 9.9% in a prospective questionnaire study restricted to individuals who previously indicated that they 'probably' or 'definitely' would attend FS screening , to 18.3% in a cross-sectional interview study that used The Health Belief Model as a framework to assess practices regarding CRC screening use .
Discussion
Main findings
This is the first review to focus on factors associated with FS screening use specifically. As such, it is the first to show that a wide range of factors are frequently associated with the use of this screening modality. It shows that, consistent with previous reviews examining factors associated with the use of CRC screening generally, male gender, higher socioeconomic status, a family history of CRC, good perceived health status, higher perceived benefits and lower perceived barriers are all frequently positively associated with FS screening use (Beydoun and Beydoun, 2008; Wools et al., 2015; Chen et al., 2017; Kiviniemi et al., 2011) . It also shows that, in contrast with previous reviews, being overweight and having one or more chronic conditions are not frequently positively associated with FS screening use specifically (Beydoun and Beydoun, 2008; Wools et al., 2015) . Indeed, having one or more chronic conditions was found to be negatively associated with FS screening use in one of three studies (no association was observed in two) Bostick et al., 1994; Larsen et al., 2006) , while being overweight was not associated with FS screening use in the one study that examined it (Larsen et al., 2006) . One possible explanation for this discrepancy is that these factors were only examined in a small number of studies. Another possible explanation is that qualitative differences between screening tests result in some factors acting as a barrier or facilitator for some tests, but not others. With regard to why having one or more chronic conditions might be negatively associated with FS screening use specifically, and not CRC screening use in general, it is possible that chronic conditions, such as diabetes and cardiovascular disease, present practical barriers in terms of getting to the hospital and performing the bowel preparation, neither of which are relevant for completing home-based faecal occult blood test kits (by the same token, chronic conditions might also act as a barrier for colonoscopy screening; further research is required to test this). Another possible explanation is that people with certain chronic conditions, such as cardiovascular disease and high blood pressure, are simply not clinically eligible for FS, and so are less likely to report having had the test for this reason. Interviews with people who have chronic diseases might help explain why these individuals are more likely to complete one CRC screening test over another. This is only one of several possible avenues for future research, with a second being to identify the specific chronic conditions that inhibit people from attending FS screening, and a third being to develop interventions for those who have one or more chronic conditions, but are nonetheless eligible to have the test.
Contradictions within the literature
There were few contradictions within the literature. Only two factors, older age and male gender, were found to be both positively and negatively associated with FS screening use. Contradictions with age are likely to be due to differences in the age categories examined. For example, Ko and colleagues, who published the one study which found a negative association between older age and FS screening use, examined FS screening use in adults over the age of 65, and included a group of 80+ year olds, for whom CRC screening is not recommended . With regards to contradictions with gender, these are more likely to be due to differences in the way in which individuals are invited for screening. For example, Blom et al., who published the one study which found a negative association between male gender and FS screening use, found that uptake was the same for men and women who were called by a nurse, but not those who had to call the centre themselves to make an appointment ).
Problems with the literature
There are several problems with the literature, the most important being the lack of/incomplete use of theory. Most studies either did not use any theory, or only used theory in part. For example, while twelve studies examined the use of one or more constructs derived from the Health Belief Model (HBM), only four included all of the model constructs and tested the theory as a whole. This issue is exacerbated by a lack of standardised measures for specific constructs. For example, in the seven studies that examined perceived benefits (one of the four constructs that comprise the HBM), scores were calculated using items varying in number and content, making it impossible to directly compare the studies.
Another important problem with the literature is that many of the studies did not explain why they were examining certain factors. For example, 'visiting a physician within the previous year' , 'having a pap smear within the previous year' (Shapiro et al., 2001 ) and 'having a cholesterol check within the previous year' (Shapiro et al., 2001 ) all effectively examined 'contact with a healthcare provider within the previous year'. It is possible that these items could have been combined in the present review, but a lack of explanation/reference to theory meant that it was not possible to assess whether these factors should be combined without introducing bias.
Problems with the search strategy
Prior to reference list searches, the database searches detected 22 articles, which equated to 52% of the total. One possible explanation as to why such a large number of papers was missed by the database searches, is that search terms were restricted to the title and abstracts of papers, and most papers examined predictors for more than one CRC screening test, and consequently did not mention FS screening (or synonyms of) within the title/abstract specifically. Had we included more general terms, such as 'bowel cancer' and 'colorectal cancer' to our search strategy, or extended search terms beyond the titles and abstracts, it is likely that those papers detected through the reference list searches would have been picked up by the database searches. However, both of these would likely have resulted in a substantial increase in the total number of papers eligible for review, and thereby prolonged the review process.
Implications for future research
This review has several implications for future research. It highlights a number of demographic subgroups for whom FS screening use is low, and would therefore benefit from the development of targeted interventions. These subgroups include women, adults under the age of 65, non-Black and non-Hispanic ethnic minority groups (e.g. Chinese, Indian and Pakistani), and people who are unmarried or divorced. In addition, this review highlights a number of modifiable psychosocial factors that could be targeted by interventions to improve FS screening use. These include the perceived barriers and benefits of screening. Existing evidence suggests that targeting these factors is likely to be effective Kerrison et al., 2016; Kerrison et al., 2017; Kerrison et al., 2018) , and that 'the patient not wanting to do the preparation', 'the healthcare provider not suggesting the test to the patient', 'the patient being worried that the test is uncomfortable or painful', and 'the patient not knowing they should have the test' are among the most important barriers to FS screening (although none have been tested in a multivariate regression, and further research confirming the importance of these barriers is also required) (Jones et al., 2010) .
Another potential area for future research, would be to conduct a full systematic review separating the predictors of the remaining CRC screening tests. As identified in this review, different factors appear to be important for different CRC screening tests, and information distinguishing which factors are important for which tests is currently lacking. Conducting a systematic review that aims to disentangle which factors are important for which tests might help inform the development of interventions for different CRC screening tests, as well as identify low uptake groups, for whom interventions can be targeted.
Limitations
This review has several limitations. Most importantly, the search strategy used was not comprehensive; it was limited to peer-reviewed articles available on PubMed, and omitted several search terms (e.g. 'non-compliance', 'under-utilisation', etc.), due to < 1% of articles being identified by the final search (as with the previous searches, the exact combination and order in which additional search terms would have been added to the search strategy would have been determined by the total number of new publications obtained by each of the possible combinations). As such, it is possible that it did not include several relevant studies. This is a common problem with rapid reviews, one which is often accepted in favour of reviewing the literature in a shorter period of time, usually because the time and resources required for a comprehensive systematic review are not available (Tricco et al., 2015) .
Another important limitation of this review is that it did not include qualitative research studies (of which the database and reference list searches identified seven (Austin et al., 2009; Hall et al., 2016; Holt, 1991; McCaffery et al., 2001; Rawl et al., 2000; Ritvo et al., 2013; Weitzman et al., 2001) ). Findings contained within these studies might help explain the associations identified within this review. For example, why it is that men are more likely to use FS screening than women. A qualitative synthesis of these studies might provide a valuable contribution to the literature.
Finally, this review did not sub-classify studies by design. In addition, no formal quality assessment was performed, and results were taken at face value. We have noted the characteristics of studies in the tables. Researchers should refer to the appendices for further information on each of the studies.
Strengths
This review had a number of strengths. Most importantly, it contained a high number of articles, and had no date restriction imposed. Furthermore, it focused entirely on FS screening use, and did not mix findings with those for other screening tests, or diagnostic FS, meaning that it was possible to extract factors that were associated with FS screening use specifically.
Conclusions
The findings of this review suggest that a number of factors, including male gender, higher socioeconomic status, a family history of CRC, good perceived health status, higher perceived benefits and lower perceived barriers are all frequently positively associated with FS screening use. In addition, the findings highlight a number of issues with the existing literature, including a lack of theory and standardised measures. Implications for future research include investigating which chronic conditions act as barriers to FS screening, as well as the development of targeted interventions for low uptake groups.
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